Agilent Technologies and Chungnam National University have agreed to develop applications, methods, technologies and software tools in the field of glycomics, the study of complex sugars.
The university aims to identify and develop biomarkers for diseases such as cancer, leading to the development of therapeutic antibody products.
The research will be jointly led by Prof Hyun Joo An of the department of analytical science and technology at Chungnam National University's Graduate School of Analytical Science and Technology (GRAST) and head of the new Asia Glycomics Education Center, and by Rudolf Grimm, Agilent's director of science and technology and manager of collaborations in the Asia-Pacific region.
Both researchers will define and conduct joint research projects to develop applications, methods or analytical tools for glycan analysis.
Under the agreement, GRAST will also develop glycomics training courses for Agilent's customers and employees to help further the advancement in the field, while Agilent Life Sciences will utilise GRAST as its strategic glycomics reference site in Korea and Southeast Asia.
